1. Home
  2. CENTA vs RARE Comparison

CENTA vs RARE Comparison

Compare CENTA & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Garden & Pet Company Nonvoting

CENTA

Central Garden & Pet Company Nonvoting

HOLD

Current Price

$37.84

Market Cap

2.3B

ML Signal

HOLD

Logo Ultragenyx Pharmaceutical Inc.

RARE

Ultragenyx Pharmaceutical Inc.

HOLD

Current Price

$26.49

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENTA
RARE
Founded
1955
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.5B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
CENTA
RARE
Price
$37.84
$26.49
Analyst Decision
Hold
Strong Buy
Analyst Count
4
20
Target Price
$36.75
$59.10
AVG Volume (30 Days)
275.8K
1.9M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
57.41
7.31
EPS
2.84
N/A
Revenue
$3,129,100,000.00
$673,000,000.00
Revenue This Year
$1.60
$13.12
Revenue Next Year
$2.04
$37.80
P/E Ratio
$13.58
N/A
Revenue Growth
N/A
20.13
52 Week Low
$25.97
$18.29
52 Week High
$40.80
$39.89

Technical Indicators

Market Signals
Indicator
CENTA
RARE
Relative Strength Index (RSI) 47.24 44.33
Support Level $36.68 $21.54
Resistance Level $40.20 $27.95
Average True Range (ATR) 1.21 1.50
MACD -0.11 0.11
Stochastic Oscillator 23.25 50.45

Price Performance

Historical Comparison
CENTA
RARE

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

Share on Social Networks: